Medigene AG (FRA:MDG1)
Germany · Delayed Price · Currency is EUR 0.0172
+0.0006 (3.61%)
Jun 30, 2026, 8:00 AM CET
Medigene AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 29, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 0 | 39 | 50 | 71 | 87 | 99 | |
Market Cap Growth | -85.17% | -22.93% | -29.07% | -18.25% | -12.11% | -45.89% |
Enterprise Value | - | 18 | 15 | 53 | 52 | 45 |
Last Close Price | 0.02 | 2.99 | 3.87 | 5.46 | 6.68 | 7.60 |
Price Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 29, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Forward PE | - | 8.88 | 8.88 | - | - | - |
PS Ratio | 0.03 | 6.43 | 1.61 | 6.78 | 10.85 | 9.40 |
PB Ratio | 0.01 | 1.84 | 1.36 | 1.58 | 1.63 | 1.21 |
P/TBV Ratio | 0.03 | 3.46 | 1.85 | 4.83 | 4.04 | 2.14 |
P/FCF Ratio | - | - | 4.57 | - | - | - |
P/OCF Ratio | - | - | 4.21 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 29, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | - | 2.94 | 0.47 | 5.10 | 6.48 | 4.25 |
EV/EBITDA Ratio | - | - | 0.45 | - | - | - |
EV/EBIT Ratio | - | - | 1.26 | - | - | - |
EV/FCF Ratio | - | - | 1.33 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 29, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | 0.13 | 0.14 | 0.10 | 0.09 | 0.10 | 0.07 |
Debt / EBITDA Ratio | - | - | 0.11 | - | - | - |
Debt / FCF Ratio | - | - | 0.34 | - | - | - |
Net Debt / Equity Ratio | -0.58 | -0.65 | -0.80 | -0.41 | -0.47 | -0.59 |
Net Debt / EBITDA Ratio | 0.78 | 0.88 | -0.90 | 3.20 | 1.04 | 2.60 |
Net Debt / FCF Ratio | 0.78 | 0.87 | -2.68 | 1.69 | 0.99 | 2.73 |
Asset Turnover | 0.21 | 0.14 | 0.56 | 0.16 | 0.09 | 0.09 |
Quick Ratio | 2.22 | 2.47 | 4.93 | 2.96 | 3.16 | 5.55 |
Current Ratio | 2.39 | 2.53 | 5.02 | 3.01 | 3.23 | 5.65 |
Return on Equity (ROE) | -63.93% | -55.69% | -20.36% | -20.38% | -42.79% | -21.57% |
Return on Assets (ROA) | -27.15% | -24.21% | 13.16% | -7.75% | -18.48% | -10.76% |
Return on Capital Employed (ROCE) | -69.20% | -65.80% | 26.40% | -16.20% | -42.10% | -20.40% |
Yields
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 29, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Earnings Yield | -6222.20% | -41.68% | -16.54% | -14.06% | -33.26% | -20.21% |
FCF Yield | -5777.39% | -40.67% | 21.89% | -15.33% | -29.10% | -18.07% |
Buyback Yield / Dilution | -2.65% | - | - | - | -0.01% | -3.77% |